Renaissance Technologies’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.97M Buy
222,052
+131,482
+145% +$4.13M 0.01% 1311
2025
Q1
$2.69M Sell
90,570
-6,000
-6% -$178K ﹤0.01% 1809
2024
Q4
$2.85M Sell
96,570
-179,630
-65% -$5.3M ﹤0.01% 1817
2024
Q3
$8.6M Sell
276,200
-370,720
-57% -$11.5M 0.01% 1119
2024
Q2
$21.9M Buy
646,920
+82,120
+15% +$2.78M 0.04% 549
2024
Q1
$36.7M Buy
564,800
+219,700
+64% +$14.3M 0.06% 410
2023
Q4
$23.6M Sell
345,100
-111,200
-24% -$7.6M 0.04% 553
2023
Q3
$23.7M Buy
456,300
+9,000
+2% +$467K 0.04% 510
2023
Q2
$26.8M Buy
447,300
+2,700
+0.6% +$162K 0.04% 539
2023
Q1
$22M Buy
444,600
+139,500
+46% +$6.9M 0.03% 666
2022
Q4
$17.4M Buy
305,100
+210,300
+222% +$12M 0.02% 788
2022
Q3
$4.45M Buy
94,800
+43,900
+86% +$2.06M 0.01% 1512
2022
Q2
$1.9M Buy
50,900
+43,600
+597% +$1.63M ﹤0.01% 2223
2022
Q1
$218K Buy
+7,300
New +$218K ﹤0.01% 3610